David M. Goldstein

Chief Tech/Sci/R&D Officer at PRINCIPIA BIOPHARMA INC.

58 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Severin Schwan	M	57	ROCHE HOLDING AG	16 years
Chris Varma	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 years
André S. Hoffmann	M	66	ROCHE HOLDING AG	28 years
Othman Laraki	M	46	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Betsy Santos	F	-	PRINCIPIA BIOPHARMA INC.	-
Daniel K. Nomura	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 years
Roberto Zoncu	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	6 years
Thomas Schinecker	M	49	ROCHE HOLDING AG	21 years
Luke Evnin	M	60	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
John Reed	M	65	PRINCIPIA BIOPHARMA INC.	-
Paul Laland	M	-	PRINCIPIA BIOPHARMA INC.	-
Pamela Klein	M	63	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	1 years
Janwillem Naesens	M	41	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Cameron Wheeler	M	45	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-
Setareh Pouraghabagher	F	53	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	2 years
Joan S Brugge	M	-	Frontier Medicines Corp. Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
DeAnne Shirley Julius	M	75	ROCHE HOLDING AG	14 years
Erich Hunziker	M	70	ROCHE HOLDING AG	10 years
Andreas Oeri	M	75	ROCHE HOLDING AG	24 years
Walter Frey	M	80	ROCHE HOLDING AG	10 years
John Bell	M	71	ROCHE HOLDING AG	19 years
Lodewijk J. R. de Vink	M	78	ROCHE HOLDING AG	9 years
Christopher Chai	M	58	PRINCIPIA BIOPHARMA INC.	7 years
Martin Babler	M	59	PRINCIPIA BIOPHARMA INC.	9 years
Peter Thompson	M	64	PRINCIPIA BIOPHARMA INC.	8 years
Paul Bulcke	M	69	ROCHE HOLDING AG	11 years
Horst Teltschik	M	83	ROCHE HOLDING AG	-
Simeon George	M	46	PRINCIPIA BIOPHARMA INC.	9 years
Wolfgang Ruttenstorfer	M	73	ROCHE HOLDING AG	4 years
Christoph Franz	M	64	ROCHE HOLDING AG	12 years
Roy C. Hardiman	M	64	PRINCIPIA BIOPHARMA INC.	5 years
Pius Baschera	M	73	ROCHE HOLDING AG	10 years
Bruno Gehrig	M	77	ROCHE HOLDING AG	9 years
Domenico Scala	M	59	ROCHE HOLDING AG	8 years
John Smither	M	71	PRINCIPIA BIOPHARMA INC.	-
Henri-Paul Meier	M	-	ROCHE HOLDING AG	-
Dan Becker	M	49	PRINCIPIA BIOPHARMA INC.	3 years
Clive Meanwell	M	67	ROCHE HOLDING AG	9 years
Arthur Levinson	M	73	ROCHE HOLDING AG	-
Alan Colowick	M	61	PRINCIPIA BIOPHARMA INC.	3 years
William Burns	M	76	ROCHE HOLDING AG	4 years
Beatrice Weder di Mauro	M	57	ROCHE HOLDING AG	10 years
Vincent Charlon	M	-	ROCHE HOLDING AG	8 years
Steve Krognes	M	56	ROCHE HOLDING AG	5 years
Jean-Jacques Garaud	M	68	ROCHE HOLDING AG	5 years
Klaus Gustav Strein	M	-	ROCHE HOLDING AG	13 years
Unni Hjelmaas	F	-	ROCHE HOLDING AG	3 years
Michael Burgess	M	61	ROCHE HOLDING AG	-
David Kabakoff	M	76	PRINCIPIA BIOPHARMA INC.	2 years
Torsten Hoffmann	M	57	ROCHE HOLDING AG	16 years
Greg S. Yap	M	-	ROCHE HOLDING AG	3 years
Shawn Tomasello	F	65	PRINCIPIA BIOPHARMA INC.	1 years
Michael Mulqueen	M	-	ROCHE HOLDING AG	13 years
Michael Byrnes	M	47	PRINCIPIA BIOPHARMA INC.	-
Olivia Ware	F	67	PRINCIPIA BIOPHARMA INC.	2 years
Luca Santarelli	M	55	ROCHE HOLDING AG	8 years
Shao Lee Lin	M	57	PRINCIPIA BIOPHARMA INC.	1 years
Christopher Vann	M	59	ROCHE HOLDING AG	22 years
Stefani Wolff	F	62	PRINCIPIA BIOPHARMA INC.	4 years
Dolca Thomas	M	53	PRINCIPIA BIOPHARMA INC.	2 years
Marc M. Gibeley	M	59	ROCHE HOLDING AG	5 years
Anton Affentranger	M	68	ROCHE HOLDING AG	-
Dirk W. Kirsten	M	56	ROCHE HOLDING AG	2 years
Bradley Bolzon	M	64	ROCHE HOLDING AG	4 years
Peter Brabeck-Letmathe	M	79	ROCHE HOLDING AG	10 years
Clarence Machado	M	60	PRINCIPIA BIOPHARMA INC.	1 years
Lewis J. Shuster	M	68	PRINCIPIA BIOPHARMA INC.	-
Stephen Hill	M	65	ROCHE HOLDING AG	2 years
Hany Massarany	M	62	ROCHE HOLDING AG	2 years
Franz Humer	M	76	ROCHE HOLDING AG	19 years
Richard Scheller	M	70	ROCHE HOLDING AG	5 years
Rolf Hänggi	M	81	ROCHE HOLDING AG	10 years
Per-Olof Attinger	M	64	ROCHE HOLDING AG	-
Eduard Enrico Holdener	M	79	ROCHE HOLDING AG	12 years
Rolf Schläpfer	M	68	ROCHE HOLDING AG	-
Gerald Heinz Möller	M	80	ROCHE HOLDING AG	-
Phyllis Whiteley	M	-	ROCHE HOLDING AG	5 years
Jürg Witmer	M	75	ROCHE HOLDING AG	21 years
Myriam Meyer Stutz	M	62	ROCHE HOLDING AG	3 years
Steven G. Gourlay	M	64	PRINCIPIA BIOPHARMA INC.	5 years
Michael Dybbs	M	49	PRINCIPIA BIOPHARMA INC.	2 years
Mohammad Masjedizadeh	M	-	PRINCIPIA BIOPHARMA INC.	5 years

Statistics

Country	Connections	% of total
Switzerland	49	59.76%
United States	33	40.24%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections